DBD earnings analysis
What we found in DBD's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Diebold Nixdorf reported $930.8 million of revenue and $1.10 of diluted EPS for the June 2026 quarter. Revenue grew 1.7% year over year and 4.3% sequentially, while EPS rose from $0.33 a year earlier and $0.14 in the prior quarter. The supplied filing extract does not include segment results, balance-sheet and cash-flow statements, detailed MD&A drivers, updated risk factors, or quantitative guidance, limiting assessment of the durability of the earnings improvement.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue returned to year-over-year growth
- Revenue was $930.8 million, up $15.8 million, or 1.7%, from $915.0 million in 2025 Q2 and up $38.8 million, or 4.3%, from $892.0 million in 2026 Q1.
- EPS increased sharply versus both comparisons
- Diluted EPS was $1.10, versus $0.33 in 2025 Q2 and $0.14 in 2026 Q1, an increase of $0.77 year over year and $0.96 sequentially.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Revenue remains below prior fourth-quarter run rate
- Revenue of $930.8 million was still $169.2 million, or 15.4%, below 2025 Q4 revenue of $1.1 billion, indicating the business remains meaningfully below its seasonally stronger fourth-quarter run rate.
- Margin and cash-flow disclosure unavailable in extract
- Gross margin, operating margin and free cash flow were not available in the supplied 10-Q extract, despite prior-quarter levels of 23.9%, 3.7% and $26 million, respectively; profitability and cash-conversion trends therefore cannot be verified from the provided filing text.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $1.1
What they said about what is next.
No quantitative revenue or EPS outlook was included in the supplied 10-Q extract; outlook may have been addressed separately in the earnings release or call.
The filing reads better than the one before it.
What came before.
- 10-Q · April 30, 2026
- Diebold Nixdorf reported Q1 2026 results, showcasing a revenue increase to $891.8 million, a 6% year-over-year growth that surpassed estimates of $859.1 million. The company generated an EPS of $0.67, significantly up…
- 10-K · February 12, 2026
- Diebold Nixdorf's 10-K shows modest topline growth in FY2025 with improving margins and materially stronger cash generation. Revenue rose to about $3.80 billion in 2025 (vs $3.75 billion in 2024), gross margin expanded…
- 10-Q · August 6, 2025
- Diebold Nixdorf reported Q2 net sales of $915.2 million, down $24.5 million (‑2.6%) versus Q2 2024, with total gross margin slightly lower at 25.6% (vs. 25.9% prior year) and operating profit of $56.2 million (operating…
- 10-K · February 25, 2025
- Diebold Nixdorf's 2024 10-K reveals a shift towards growth in the Banking segment, achieving $2.76 billion in total revenue, up from $3.46 billion in 2023, driven by ATM unit sales and a PIS/COFIN tax recovery in…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing DBD makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever